Therapy against organophosphate poisoning: The importance of anticholinergic drugs with antiglutamatergic properties

Toxicology and Applied Pharmacology

Volumn 232, Issue 2, 2008, Pages 351-358

  Weissman, Ben Avi ^a   Raveh, Lily ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

Caramiphen; Cognitive dysfunction; Neurodegeneration; Organophosphate; Sarin; Soman

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ACETYLCHOLINE; ANTICONVULSIVE AGENT; ATROPINE; BENACTYZINE; CARAMIPHEN; CARBAMIC ACID; CHEMICAL WARFARE AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DIZOCILPINE; ENZYME ACTIVATOR; GACYCLIDINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE; MEMANTINE; MUSCARINIC RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORGANOPHOSPHATE; OXIME; PROCYCLIDINE; PYRIDOSTIGMINE; SARIN; SCOPOLAMINE; SIGMA OPIATE RECEPTOR; SOMAN; TRIHEXYPHENIDYL;

ANTICONVULSANT ACTIVITY; BRAIN DAMAGE; COGNITIVE DEFECT; CONVULSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; INTOXICATION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; REVIEW; SURVIVAL; SYNAPTIC MEMBRANE; TERRORISM;

ANIMALS; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; CYCLOPENTANES; EXCITATORY AMINO ACID ANTAGONISTS; GAS POISONING; GLUTAMIC ACID; HUMANS; PHOSPHORIC ACID ESTERS;

EID: 52049110479     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.07.005     Document Type: Review

References (86)

1. Albuquerque E.X., Deshpande S.S., Kawabuchi M., Aracava Y., Idriss M., Rickett D.L., and Boyne A.F. Multiple actions of anticholinesterase agents on chemosensitive synapses: molecular basis for prophylaxis and treatment of organophosphate poisoning. Fundam. Appl. Toxicol. 5 (1985) S182-203
2. Allon N., Rabinovitz I., Manistersky E., Weissman B.A., and Grauer E. Acute and long-lasting cardiac changes following a single whole-body exposure to sarin vapor in rats. Toxicol. Sci. 87 (2005) 385-390
3. Anderson D.R., Harris L.W., Lennox W.J., and Solana R.P. Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure. Drug Chem. Toxicol. 14 (1991) 1-19
4. Annels S.J., Ellis Y., and Davies J.A. Non-opioid antitussives inhibit endogenous glutamate release from rabbit hippocampal slices. Brain Res. 564 (1991) 341-343
5. Apland J.P., and Braitman D.J. Effects of non-opioid antitussives on epileptiform activity and NMDA responses in hippocampal and olfactory cortex slices. Brain Res. 529 (1990) 277-285
6. Berry W.K., and Davies D.R. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19 (1970) 927-934
7. Bodjarian N., Carpentier P., Baubichon D., Blanchet G., and Lallement G. Involvement of non-muscarinic receptors in phosphoinositide signalling during soman-induced seizures. Eur. J. Pharmacol. 289 (1995) 291-297
8. Braitman D.J., and Sparenborg S. MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res. Bull. 23 (1989) 145-148
9. Carpentier P., Foquin-Tarricone A., Bodjarian N., Rondouin G., Lerner-Natoli M., Kamenka J.M., Blanchet G., Denoyer M., and Lallement G. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 15 (1994) 837-851
10. Chebabo S.R., Santos M.D., and Albuquerque E.X. The organophosphate sarin, at low concentrations, inhibits the evoked release of GABA in rat hippocampal slices. Neurotoxicology 20 (1999) 871-882
11. Church J., and Fletcher E.J. Blockade by sigma site ligands of high voltage-activated Ca2+channels in rat and mouse cultured hippocampal pyramidal neurones. Br. J. Pharmacol. 116 (1995) 2801-2810
12. Church J., Shacklock J.A., and Baimbridge K.G. Dextromethorphan and phencyclidine receptor ligands: differential effects on K(+)-and NMDA-evoked increases in cytosolic free Ca2+concentration. Neurosci. Lett. 124 (1991) 232-234
13. de Groot D.M., Bierman E.P., Bruijnzeel P.L., Carpentier P., Kulig B.M., Lallement G., Melchers B.P., Philippens I.H., and van Huygevoort A.H. Beneficial effects of TCP on soman intoxication in guinea pigs: seizures, brain damage and learning behaviour. J. Appl. Toxicol. 21 Suppl 1 (2001) S57-65
14. de Groot D.M.G., Bierman E.P.B., and Van Huygenvort A.H.B. Involvement of acetylcholine and glutamate in soman-induced brain damage. Micron. Microsc. Acta 21 (1990) 247-248
15. Deshpande S.S., Smith C.D., and Filbert M.G. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Arch. Toxicol. 69 (1995) 384-390
16. Diana G., Scotti de Carolis A., Popoli P., Pezzola A., and Sagratella S. Non-opioid antitussives potentiate some behavioural and EEG effects of N-methyl-d-aspartate channel blockers. Life Sci. 52 (1993) 1547-1557
17. Dunn M.A., and Sidell F.R. Progress in medical defense against nerve agents. JAMA 262 (1989) 649-652
18. Essig C.F., and Hampson J.L. Effect of parpanit on brain wave changes induced by diisopropyl fluorophosphate. Science 111 (1950) 38
19. Filliat P., Baubichon D., Burckhart M.F., Pernot-Marino I., Foquin A., Masqueliez C., Perrichon C., Carpentier P., and Lallement G. Memory impairment after soman intoxication in rat: correlation with central neuropathology. Improvement with anticholinergic and antiglutamatergic therapeutics. Neurotoxicology 20 (1999) 535-549
20. Fletcher E.J., Church J., Abdel-Hamid K., and MacDonald J.F. Blockade by sigma site ligands of N-methyl-d-aspartate-evoked responses in rat and mouse cultured hippocampal pyramidal neurones. Br. J. Pharmacol. 116 (1995) 2791-2800
21. Fosbraey P., Wetherell J.R., and French M.C. Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J. Neurochem. 54 (1990) 72-79
22. Harris L.W., Talbot B.G., Lennox W.J., Anderson D.R., and Solana R.P. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication. Drug Chem. Toxicol. 14 (1991) 265-281
23. Hashizume N., Ihara H., Ohtsuka M., and Kadowaki H. [Blood amino acid levels in sarin poisoning patients]. Rinsho Byori 45 (1997) 785-789
24. Haug K.H., Myhrer T., and Fonnum F. The combination of donepezil and procyclidine protects against soman-induced seizures in rats. Toxicol. Appl. Pharmacol. 220 (2007) 156-163
25. Hudkins R.L., and DeHaven-Hudkins D.L. M1 muscarinic antagonists interact with sigma recognition sites. Life Sci. 49 (1991) 1229-1235
26. Jacobsson S.O., Cassel G.E., Karlsson B.M., Sellstrom A., and Persson S.A. Release of dopamine, GABA and EAA in rats during intrastriatal perfusion with kainic acid, NMDA and soman: a comparative microdialysis study. Arch. Toxicol. 71 (1997) 756-765
27. Johnson P.S., and Michaelis E.K. Characterization of organophosphate interactions at N-methyl-d-aspartate receptors in brain synaptic membranes. Mol. Pharmacol. 41 (1992) 750-756
28. Kassa J. Therapeutic and neuroprotective efficacy of pharmacological pretreatment and antidotal treatment of acute tabun or soman poisoning with the emphasis on pretreatment drug PANPAL. Arh. Hig. Rada Toksikol. 57 (2006) 427-434
29. Kim W.-S., Cho Y., Kim J.-C., Huang Z.-Z., Park S.-H., Choi E.-K., Shin S., Nam S.-Y., Kang J.-K., Hwang S.-Y., and Kim Y.-B. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs. Eur. J. Pharmacol. 525 (2005) 135-142
30. Koplovitz I., Schulz S., Shutz M., Railer R., Macalalag R., Schons M., and McDonough J. Combination anticonvulsant treatment of soman-induced seizures. J. Appl. Toxicol. 21 Suppl. 1 (2001) S53-S55
31. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., and Blanchet G. Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563 (1991) 234-240
32. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., Sentenac-Roumanou H., and Blanchet G. [Involvement of glutamatergic system of amygdala in generalized seizures induced by soman: comparison with the hippocampus]. C. R. Acad. Sci. III 313 (1991) 421-426
33. Lallement G., Carpentier P., Pernot-Marino I., Baubichon D., Collet A., and Blanchet G. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: an autoradiographic study. Neurotoxicology 12 (1991) 655-664
34. Lallement G., Carpentier P., Collet A., Baubichon D., Pernot-Marino I., and Blanchet G. Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology 13 (1992) 557-567
35. Lallement G., Denoyer M., Collet A., Pernot-Marino I., Baubichon D., Monmaur P., and Blanchet G. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells. Neurosci. Lett. 139 (1992) 104-107
36. Lallement G., Delamanche I.S., Pernot-Marino I., Baubichon D., Denoyer M., Carpentier P., and Blanchet G. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an omega 3 site ligand. Brain. Res. 618 (1993) 227-237
37. Lallement G., Pernot-Marino I., Baubichon D., Burckhart M.F., Carpentier P., and Blanchet G. Modulation of soman-induced neuropathology with an anticonvulsant regimen. NeuroReport 5 (1994) 2265-2268
38. Lallement G., Pernot-Marino I., Foquin-Tarricone A., Baubichon D., Piras A., Blanchet G., and Carpentier P. Antiepileptic effects of NBQX against soman-induced seizures. NeuroReport 5 (1994) 425-428
39. Lallement G., Pernot-Marino I., Foquin-Tarricone A., Baubichon D., Piras A., Blanchet G., and Carpentier P. Coadministration of atropine, NBQX and TCP against soman-induced seizures. NeuroReport 5 (1994) 1113-1117
40. Lallement G., Baubichon D., Clarencon D., Galonnier M., Peoc'h M., and Carpentier P. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology 20 (1999) 675-684
41. Leadbeater L., Inns R.H., and Rylands J.M. Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5 (1985) S225-231
42. Lipp J.A. Effect of diazepam upon soman-induced seizure activity and convulsions. Electroencephalogr. Clin. Neurophysiol. 32 (1972) 557-560
43. Madill H.D., Stewart W.C., and Savoie M.L. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning. Can. J. Physiol. Pharmacol. 46 (1968) 559-565
44. McDonough Jr. J.H., and Shih T.M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17 (1993) 203-215
45. McDonough Jr. J.H., and Shih T.M. A study of the N-methyl-d-aspartate antagonistic properties of anticholinergic drugs. Pharmacol. Biochem. Behav. 51 (1995) 249-253
46. McDonough Jr. J.H., and Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 21 (1997) 559-579
47. McLean M.J., Gupta R.C., Dettbarn W.D., and Wamil A.W. Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol. Appl. Pharmacol. 112 (1992) 95-103
48. Munirathinam S., and Bahr B.A. Repeated contact with subtoxic soman leads to synaptic vulnerability in hippocampus. J. Neurosci. Res. 77 (2004) 739-746
49. Myhrer T., Enger S., and Aas P. Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality. Eur. J. Pharmacol. 483 (2004) 271-279
50. Myhrer T., Nguyen N.H., Andersen J.M., and Aas P. Protection against soman-induced seizures in rats: relationship among doses of prophylactics, soman, and adjuncts. Toxicol. Appl. Pharmacol. 196 (2004) 327-336
51. Myhrer T., Enger S., and Aas P. Efficacy of immediate and subsequent therapies against soman-induced seizures and lethality in rats. Basic Clin. Pharmacol. Toxicol. 98 (2006) 184-191
52. Myhrer T., Enger S., and Aas P. Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman. Neurochem. Res. 33 (2008) 348-354
53. Obrenovitch T.P., Urenjak J., and Zilkha E. Evidence disputing the link between seizure activity and high extracellular glutamate. J. Neurochem. 66 (1996) 2446-2454
54. Olney J.W., Price M.T., Labruyere J., Salles K.S., Frierdich G., Mueller M., and Silverman E. Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur. J. Pharmacol. 142 (1987) 319-320
55. Pavlovsky L., Browne R.O., and Friedman A. Pyridostigmine enhances glutamatergic transmission in hippocampal CA1 neurons. Exp. Neurol. 179 (2003) 181-187
56. Pontecorvo M.J., Karbon E.W., Goode S., Clissold D.B., Borosky S.A., Patch R.J., and Ferkany J.W. Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agents. Brain Res. Bull. 26 (1991) 461-465
57. Raveh L., and Weissman B.A. The rapid activation of the glutamatergic system in organophosphate poisoning (2008), Nova Science Publishers, Inc., New York
58. Raveh L., Chapman S., Cohen G., Alkalay D., Gilat E., Rabinovitz I., and Weissman B.A. The involvement of the NMDA receptor complex in the protective effect of anticholinergic drugs against soman poisoning. Neurotoxicology 20 (1999) 551-559
59. Raveh L., Weissman B.A., Cohen G., Alkalay D., Rabinovitz I., Sonego H., and Brandeis R. Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology 23 (2002) 7-17
60. Raveh L., Brandeis R., Gilat E., Cohen G., Alkalay D., Rabinovitz I., Sonego H., and Weissman B.A. Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction. Toxicol. Sci. 75 (2003) 108-116
61. Raveh L., Rabinovitz I., Gilat E., Egoz I., Kapon J., Stavitsky Z., Avi Weissman B., and Brandeis R. Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen. Toxicol. Appl. Pharmacol. 227 (2008) 155-162
62. Reynolds I.J., and Miller R.J. [3H]MK801 binding to the N-methyl-d-aspartate receptor reveals drug interactions with the zinc and magnesium binding sites. J. Pharmacol. Exp. Ther. 247 (1988) 1025-1031
63. Rocha E.S., Chebabo S.R., Santos M.D., Aracava Y., and Albuquerque E.X. An analysis of low level doses of cholinesterase inhibitors in cultured neurons and hippocampal slices of rats. Drug Chem. Toxicol. 21 Suppl 1 (1998) 191-200
64. Rocha E.S., Santos M.D., Chebabo S.R., Aracava Y., and Albuquerque E.X. Low concentrations of the organophosphate VX affect spontaneous and evoked transmitter release from hippocampal neurons: toxicological relevance of cholinesterase-independent actions. Toxicol. Appl. Pharmacol. 159 (1999) 31-40
65. Roesler R., Quevedo J., and Schroder N. NMDA receptors might be involved in the impairing effects of procyclidine on cognition. J. Clin. Psychopharmacol. 23 (2003) 666-667 author reply 667-668
66. Sanger D.J., and Jackson A. Effects of phencyclidine and other N-methyl-d-aspartate antagonists on the schedule-controlled behavior of rats. J. Pharmacol. Exp. Ther. 248 (1989) 1215-1221
67. Schenk J., Loffler W., and Weger N. Therapeutic effects of HS-3, HS-6, benactyzine, and atropine in soman poisoning of dogs. Arch. Toxicol. 36 (1976) 71-81
68. Shih T.M. Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacology (Berl) 78 (1982) 170-175
69. Shih T.M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7 (1990) 105-116
70. Shih T.M., and McDonough Jr. J.H. Neurochemical mechanisms in soman-induced seizures. J. Appl. Toxicol. 17 (1997) 255-264
71. Shih T., McDonough Jr. J.H., and Koplovitz I. Anticonvulsants for soman-induced seizure activity. J. Biomed. Sci. 6 (1999) 86-96
72. Shih T.M., Duniho S.M., and McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol. Appl. Pharmacol. 188 (2003) 69-80
73. Sills M.A., and Loo P.S. Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and l-glutamate. Mol. Pharmacol. 36 (1989) 160-165
74. Solana R.P., Gennings C., Anderson D., Carter Jr. W.H., Carchman R.A., and Harris L.W. Comparing the response surfaces of two cholinolytics when used in combination with physostigmine as a pretreatment against organophosphate challenge. Drug Chem. Toxicol. 12 (1989) 197-219
75. Solberg Y., and Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends Pharmacol. Sci. 18 (1997) 183-185
76. Sparenborg S., Brennecke L.H., and Braitman D.J. Prevention of soman neurotoxicity by non-opioid antitussives. Neurotoxicology 11 (1990) 509-520
77. Stitcher D.L., Harris L.W., Heyl W.C., and Alter S.C. Effects of pyridostigmine and cholinolytics on cholinesterase and acetylcholine in Soman poisoned rats. Drug Chem. Toxicol. 1 (1978) 355-362
78. Szilagyi M., Gray P.J., and Dawson R.M. Effects of the nerve agents soman and tabun on the uptake and release of GABA and glutamate in synaptosomes of guinea pig cerebral cortex. Gen. Pharmacol. 24 (1993) 663-668
79. Taylor P. Anticholinesterase agents. In: Hardman L.E.L.J.G., and Gilman A.G. (Eds). The Pharmacological Basis of Therapeutics (2001), McGraw-Hill;Inc., New York 175-191
80. Tortella F.C., Witkin J.M., and Musacchio J.M. Caramiphen: a non-opioid antitussive with potent anticonvulsant properties in rats. Eur. J. Pharmacol. 155 (1988) 69-75
81. Wade J.V., Samson F.E., Nelson S.R., and Pazdernik T.L. Changes in extracellular amino acids during soman-and kainic acid-induced seizures. J. Neurochem. 49 (1987) 645-650
82. Weissman B.A., and Raveh L. Peripheral benzodiazepine receptors: on mice and human brain imaging. J. Neurochem. 84 (2003) 432-437
83. Wood S.J., and Tattersall J.E. An improved brain slice model of nerve agent-induced seizure activity. J. Appl. Toxicol. 21 Suppl. 1 (2001) S83-86
84. Zachariah E., Kumari V., Galea A., Das M., Mehrotra R., Taylor D., Ruprah M., and Sharma T. Effects of oral procyclidine administration on cognitive functions in healthy subjects: implications for schizophrenia. J. Clin. Psychopharmacol. 22 (2002) 224-226
85. Zarnowski T., Kleinrok Z., Turski W.A., and Czuczwar S.J. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice. J. Neural Transm. Gen. Sect. 97 (1994) 1-12
86. Zhou Z., Dai X., Gu X., Sun Y., Zheng G., and Zheng J. Memantine alleviates toxicity induced by dichlorvos in rats. J. Occup. Health 47 (2005) 96-101